Table 1 Baseline demographics.

From: The implications of subretinal fluid in pachychoroid neovasculopathy

Parameters

Total PNV (n = 81)

Exudative PNV (n = 26)

Non-exudative PNV (n = 55)

P value

Male: Female

58:23

17:9

41:14

0.393*

Age, years

60.4 ± 12.4

55.3 ± 15.5

62.7 ± 9.9

0.030

BCVA, logMAR

0.10 ± 0.17

0.23 ± 0.21

0.03 ± 0.09

 < 0.001*

IOP, mmHg

14.2 ± 2.7

0.14 ± 0.56

13.81 ± 0.35

0.064*

S.E, diopters

0.24 ± 1.34

0.07 ± 0.31

0.33 ± 0.17

0.860*

DM, n (%)

9 (11.1)

0 (0)

9 (16.4)

0.052

Hypertension, n (%)

25 (30.9)

7 (26.9)

18 (32.7)

0.620§

Previous CSC episode

Number of eyes (%)

27 (33.3)

17 (65.4)

10 (18.2)

 < 0.001§

The period from CSC episode to the diagnosis of PNV, months

22.8 ± 9.0

22.8 ± 9.6

23.0 ± 8.2

0.880*

Pseudophakia, n (%)

5 (6.2)

1 (3.8)

4 (7.3)

1.000

  1. PNV, pachychoroid neovasculopathy; BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; S.E, Spherical equivalent; DM, Diabetes mellitus; CSC, Central serous chorioretinopathy.
  2. Continuous variables are reported as mean value (± SD).
  3. *Mann whiney test; Independent t-test; Fisher's exact test; §Chi-square test.